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When the replication of a plasmid based on sucrose selection is deregulated via the inc1 and inc2 mutations, high
copy numbers (7,000 or greater) are attained while the growth rate on minimal medium is negligibly affected.
Adaptions were assumed to be required in order to sustain the growth rate. Proteomics indicated that indeed a
number of adaptations occurred that included increased expression of ribosomal proteins and 2-oxoglutarate
dehydrogenase. The operating space prescribed by a basic flux model that maintained phenotypic traits (e.g.
growth, byproducts, etc.) within typical bounds of resolution was consistent with the flux implications of the
proteomic changes.Background
The plasmid pNTC8485 replicates in E. coli and can be
used as a platform for DNA vaccine production [1,2].
Antibiotic-free selection is used where a small antisense
RNA is produced as opposed to a heterologous protein
(e.g. β-lactamase) [3]. The small RNA binds to a
chromosomally-encoded sacB transcript. Translation of
the sacB transcript results in toxicity in a sucrose back-
ground unless the plasmid-encoded RNA is produced
and then hybridizes with the transcript.
Previously, we reported on the effect of introducing
the inc1 and inc2 mutations into this already high
copy number plasmid [4]. The inc1 and inc2 muta-
tions deregulate plasmid replication by further weak-
ening the RNA I-RNA II interactions [5]. The reasons
behind introducing these mutations were to: (i) in-
crease the DNA yield achievable in processes that aim
to produce DNA for vaccines or transfection purposes,
(ii) assess the impact on growth, (iii) determine if the
resulting amplification was similar to that observed for
very low copy plasmids, and (iv) investigate whether inte-
gration or alterations in replication fidelity occurred. The* Correspondence: md0q@andrew.cmu.edu
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unless otherwise stated.second and third aspects were considered to shed new
light on replication and the capacity of host cell metabol-
ism in the context of producing very high copy number
plasmids that do not produce heterologous protein.
After introducing the mutations, plasmid copy num-
bers (PCNs) ranging from 7,000 (early log phase) to
15,000 (onset of stationary phase) resulted when growth
occurred on minimal medium. The growth phase and
temperature influenced the PCN. Despite our starting
point for copy number being orders of magnitude higher
than Tomizawa and Som’s prior work [5], in LB medium
the copy number was increased by a factor of 4- to 6-
fold that was comparable to that achieved when the
same mutations were introduced into very low copy
number plasmids (ca. 3–30). Over a multi-generation
batch cultivation cycle, no mutations were detected
through sequencing the whole plasmid indicating that
the host’s replication fidelity was maintained despite the
high copy numbers. Also, the isolated plasmid was pri-
marily super-coiled where topoisomers comprised the
bulk of heterogeneity. Interestingly, the maximal specific
growth rate of cells harboring the deregulated plasmid
was not reduced when growth occurred in minimal
medium [4].
The low impact on growth rate can be attributed, in
part, to the differential expense of protein versus DNAThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mass of an amino acid. The ATP required per bond dur-
ing DNA polymerization is about one-third of that
needed for protein synthesis [6]. Thus, when combined,
the ATP cost per unit mass is about one-tenth less for
DNA polymerization than for protein polymerization.
Additionally, as opposed to producing an antibiotic re-
sistance marker protein (e.g. β-lactamase), which can
comprise up to 18% of cellular protein [7], a short anti-
sense RNA is expressed from the plasmid. On a per
mass basis, RNA polymerization is also less ATP-
intensive than the heterologous protein polymerization
associated with conventional plasmids. Considering now
the precursor burden, RNA breaks down faster in the
cell than protein. Thus, the cycling RNA precursors can
form their own pool that once established, less carbon is
withdrawn from central metabolism due to rapid recycle.
Thus, when compared at similar copy numbers, the pre-
cursor or carbon “burden” associated with the inc mu-
tant plasmids can be envisioned to be lower than one
would expect for conventional β-lactamase expressing
plasmids.
Nonetheless, maintaining copies number ranging from
7,000 to 15,000 for a 3740 base pair plasmid represents
the addition of several or more genome equivalents of
DNA to the cell (i.e. 7 103 × 3.7 103/4.6 106 = 5.6). Thus,
while the energetics associated with synthesizing and
maintaining the deregulated, sucrose-selected plasmids
can be estimated to be less expensive than that for a
conventional plasmid, the nil impact on nil growth could
nonetheless be enabled by metabolic and other adapta-
tions. For example, the de novo synthesis of deoxyribo-
nucleoside triphosphates can require about 10 ATPs per
molecule. The transcription from some of the more than
7000 extra genes that are available in a transformed cell
will produce RNA. This RNA will degrade and the
breakdown products will have to be converted back to
ribonucleoside triphosphates prior to repolymerization.
Thus, a number of impacts can be envisioned in the ag-
gregate albeit per plasmid, they appear to be less than
that normally associated with conventional plasmids.
To investigate if significant adaptations occurred, we
pursued a two-pronged approach: (i) flux modeling and
(ii) determining the changes within the proteome. The
aim of the modeling was to determine what metabolic
flux scenarios would allow for the plasmid-containing
cells to grow at the measured rate (0.2. h−1) subject to
measurements and the associated resolution of the by-
products and yield on glucose. Such feasible flux scenar-
ios could assist with interpreting the changes in the
proteome. Additionally, alterations in nonmetabolic sys-
tems could emerge in the proteomic results that could
further illuminate how cells may adapt to deregulated
plasmid synthesis.Methods
Network model & flux scenario generation
The simple network model used is shown in Figure 1
and it is based on one previously used to assess the
metabolic impact of plasmid production when β-
lactamase is also synthesized [8]. The mainstream glyco-
lytic and hexose monophosphate (HMP) pathways are
represented as well as the tricarboxylic acid (TCA) cycle.
Precursor diversions to biomacromolecules are also de-
noted where as previously done [8], the biosynthetic
loads were based on published compositions and stoichi-
ometries for precursor use [6].
Cells containing deregulated plasmid will experience in-
creased DNA and RNA synthesis. The extra plasmid DNA
will exert an increased precursor and ATP demand. How-
ever, the precursor load imposed by DNA is not normally
high. For a cell growing at 0.2 h−1 with a cell mass yield
(YX/S) of 0.45 g cell/g glucose, the combined precursor load
(i.e. total use of R5P, 3PG, and OAA) to deoxyribonucleo-
tides can be estimated to be 0.04 mmol/g cell h, which is
quite small compared to the glucose flux that is equal to
2.5 mmol/g h [6]. For 10 genome equivalents of DNA, the
total precursor flux on a mmol/g cell h basis would be less
than 10% of the glucose flux. The RNA l and RNA ll associ-
ated with plasmid replication as well as the small RNA that
permits for selection via binding to the chromosomally-
encoded sacB transcript will also be increasingly synthe-
sized in plasmid-containing cells. However, rapid RNA
turnover could allow for extensive recycling thereby redu-
cing the net de novo synthesis burden on precursors. ATP
use for repolymerization, however, could increase thereby
lowering the ATP yield and increasing the apparent main-
tenance energy. As for wild-type cells, additional mainten-
ance costs such as leaky membranes [9] might also prevail
and possibly be exacerbated in transformed cells due to
plasmid packing and partitioning effects [10].
One modeling approach would be to attempt to quan-
titatively account for all the aforementioned factors. For
cells hosting β-lactamase encoding plasmids, such an ap-
proach provided yield and flux scenario predictions that
spanned a range of promoter strengths and other uncer-
tainties [8]. However, in this case, because there is no
heterologous protein expression and thus plasmid pro-
duction is relatively metabolically inexpensive from the
carbon use standpoint, the problem of flux scenario gen-
eration can be first done in a simpler manner. Namely,
the flux scenarios can be elucidated that can account for
the similar phenotypes of the untransformed and trans-
formed cells. This takes advantage of the fact that a
number of constraints that define the phenotype are well
known in terms of values and typical resolution. These
constraints are YX/S, byproduct fluxes, and growth rate.
These scenarios can be generated by initially assuming
that precursor fluxes to DNA synthesis in both plasmid-
Figure 1 Metabolic network for flux analysis. Network used to model the central metabolism of E. coli. Metabolite abbreviations are αKG:
α-ketoglutarate; 2PG: 2-phosphoglycerate; 3PG: 3-phosphoglycerate; 6PG: 6-phosphogluconate; 6PGL: 6-phosphogluconolactone; AcCoA:
acetyl-coenzyme A; BPG: 1,3-bisphosphoglycerate; CIT: citrate; DHAP: dihydroxyacetone phosphate; E4P: erythrose 4-phosphate; F6P: fructose-6-
phosphate; FBP: fructose-1,6-bisphosphate; FUM: fumarate; G6P: glucose-6-phosphate; GAP: glyceraldehyde phosphate; ICIT: isocitrate; MAL:
malate; OAA: oxaloacetate; PEP: phosphoenolpyruvate; PYR: pyruvate; R5P: ribose-5-phosphate; Ru5P: ribulose-5-phosphate; S7P: sedoheptulose-7-
phosphate; SUC: succinate; S-CoA: succinyl-coenzyme A; and X5P: xylulose-5-phosphate. Specific fluxes shown are those associated with glucose
uptake (rGLU), hexose monophosphate pathway (rHMP), transaldolase (rTA), transketolase (rTK1, rTK2), tricarboxylic acid cycle (rTCA), pyruvate kinase (rPYK),
malic enzyme (rME), anaplerotic replenishment of OAA (rANA), and formation of lactate and acetate (rLAC, rACE).
Meade et al. Microbial Cell Factories  (2015) 14:31 Page 3 of 13free and -containing cells is not large compared to other
fluxes. This still allows for an adaptive space by permit-
ting total ATP production to vary subject to the fluxes
must satisfy the phenotypic constraints and their rangeof resolution. That is, for all the flux scenarios, YX/S
must fall into the experimentally resolved bounds pre-
scribed by, for example, 0.42 ± 0.03 g cell/ g glucose. Es-
sentially this amounts to finding flux scenarios that
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(MIPs), which are defined by sets of largely similar mea-
surements and their resolution bounds. These scenarios,
in turn, prescribe the adaptive flux space that exists.
Some of the flux scenarios found may turn out to
more likely correspond to plasmid-containing cells. For
example, in some scenarios the value of the mass yield
on ATP (YX/ATP) might be lower. As noted before, more
ATP production subject to fixed growth rate and other
phenotypic features could be used to support the ATP
costs associated with RNA repolymerization, DNA
polymerization, and other processes that contribute to
apparent maintenance. Thereafter, the impact of increas-
ing the DNA biosynthetic load can then be tested and
how the scenarios change can be determined.
Overall, the different flux scenarios associated with
MIPs can be determined. The overarching idea is to see
how far a “normal cell” can be stretched in terms of its
fluxes while its phenotype in terms of yield, glucose up-
take (i.e. YX/S), and byproducts is fixed by measurements
and resolution bounds. From a more mathematical per-
spective, a related idea is finding clonal solutions that
differ by a small “epsilon” value from the true (or opti-
mal) value [11]. Such solutions can be suboptimal, but
they differ from the global optimal solution by a small,
and often hard to distinguish margin.
Finding these flux scenarios entails solving
MIN Z ð1aÞ
Subject to
Ar ¼ b ð1bÞ
rlac ¼ 0 ð1cÞ
tight: rac = 1 or loose as
rac≥0:8 ð1dÞ
rac≤1:2 ð1eÞ
rglu≥2:469 ð1fÞ
rglu≤2:849 ð1gÞ
rATP≥20 ð1hÞ
rATP≤28:6 ð1iÞ
In the above, Z corresponds to an objective function
such as minimizing a particular flux. The first constraint
(1b) is the cell composition-based biosynthetic load and
flux balance matrix that is typically used in this kind of
problem and based on prior work [8]. Eqn (1c) accounts
for the nil lactate formation that was measured in the case
of plasmid-containing or -deficient cells [4]. The acetate
production during exponential growth at a specific growth
rate of 0.2 h−1 was found to be not significantly differentin biological triplicates of untransformed and transformed
cells and equal to about 1 mmol/g cell h with 20% vari-
ation [4]. As shown, either a tight formulation with acetate
flux fixed at 1 mmol/g h or a looser formulation within
resolution bounds can be used to see the effect on the
feasible flux sets. The range of glucose flux allowed by
Eqns (1f) and (1g) permits YX/S to be within the measured
range of 0.42 ± 0.03 g cell/g glucose. Finally, the range per-
mitted for ATP production allows for YX/ATP to fall in the
range of 7 to 10 g cell/mol ATP for an assumed P/O ratio
of 2.0 for NADH-linked oxidative phosphorylation and a
value of 1.0 for FADH-linked processes.
If each flux is individually minimized (or maximized
via MIN – ri), then the flux scenarios that populate the
MIPs can be determined. While a mixed integer pro-
gram could determine the extreme points [12], this
problem is small enough such that iterating through
each flux provides a means to classify the results in
terms of which metabolic reactions are simultaneously
maximized or minimized for each flux solution. The flux
sets, in turn, can inform on how a cell could adapt its
fluxes to maintain the specific growth rate by producing
more or less ATP while also keeping by-products and
other phenotypic features within experimentally resolv-
able ranges. Moreover, some of these flux scenarios may
map to changes in the proteome where a subset of flux
values and the level of associated enzymes in the prote-
ome both change in a correlated manner. Those that do
may then inform on how the host adapted to deregu-
lated plasmid synthesis when the plasmid does not en-
code a heterologous protein.
Proteomics
Host strains & plasmids
E. coli DH5α with sacB encoded in the chromosome
(DH5α attλ::P5/6 6/6-RNA-IN- SacB, catR) and plasmid
pNTC8485-EGFP (3,740 bp) were obtained from the Na-
ture Technology Corporation (Lincoln, NE). The corre-
sponding product identifiers are NTC-DV8485-LV and
NTC-DVU-CC1. The inc1 and inc2 (single and double)
mutations were introduced to pNTC8485-EGFP as pre-
viously described [4]. The inc2 mutation was found to
have a greater effect; hence, the proteomics experiments
compared the untransformed host to that of a cell host-
ing the plasmid with an inc2 mutation.
Quantitative proteomic analysis using iTraq
To generate samples for proteomic analysis, 500 ml cul-
tures of host cells and those harboring a mutant (inc2)
plasmid were grown in duplicate in M9 medium with
0.4 and 8% (by weight) glucose and sucrose. Two bio-
logical replicates of host and transformed cells were
used. When the cultures reached mid-exponential phase
(OD ~ 1.5), 250 ml of each culture was harvested by
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tracted from culture pellets by the addition of 10 ml/mg
pellet (wet weight) of buffer A (50 mM Tris–HCl, 50
mM NaCl, 0.5 mM EDTA, 5% glycerol, pH 7.5) plus 1
mg/ml lysozyme. Mixtures were incubated on ice for 10
minutes prior to sonication and centrifugation of debris.
Supernatants were decanted, flash-frozen, and stored
at −80°C.
The labeling of protein samples with iTRAQ tags, frac-
tionation using two-dimensional liquid chromatography,
identification of differentially expressed proteins by
TOF/TOF tandem MS, and statistical analysis were per-
formed as described in a prior report with only slight
modification [13]. Briefly, 100 μg of total protein per
sample was denatured by SDS, reduced using tris(2-car-
boxyethyl)phosphine, digested overnight with trypsin,
and labeled with the 8-plex iTRAQ isobaric tags accord-
ing to the iTRAQ manufacturer’s instructions (Applied
Biosystems, Foster City, CA). Labeled protein samples
(duplicates of host cell or inc2 mutants harvested at
mid-exponential or stationary phase) were pooled and
half of the sample (400 μg) composed one 8-plex experi-
mental run. Samples were fractionated by successive
strong cation exchange and reverse phase chromatog-
raphy prior to plate spotting and analysis using the ABI
4800Plus MALDI-TOF/TOF tandem MS system. Protein
identification and relative abundance quantitation was
performed using ProteinPilot software 3.0 (Applied Bio-
systems) and searches utilized the E. coli proteome data-
base (Swiss-Prot/UniProt release 2011_11). The data was
analyzed using replicate correlation analysis, principal
component analysis, and a t-test. A change was consid-
ered to be significant if a protein in a cell containing a
mutant plasmid was < 0.5 or > 2.0 that of the host, and
p < 0.05. The experiments were conducted at the Gen-
omics, Proteomics and Bioinformatics Center (Harvard
University, Cambridge, MA) and we wish to thank Dr.
Manoj Bhasin for his assistance with the data analysis.
In this paper, only the exponential phase cells are com-
pared because these are more amenable to flux analysis.
Results
Table 1 summarizes the different flux sets associated
with the MIP described by Eqn (1). All the sets shown
correspond to constraining acetate production to be 1
mmol/g cell h. If the problem is instead solved using a
wider byproduct range (1d,e), the results are similar as
in Table 1 (not shown) in terms of scenario types, but
the individual flux values range even further. Thus,
Table 1 presents a more conservative or compressed flux
space than that posed by 0.8 ≤ rac ≤ 1.2 plus the other
constraints (1f – 1i).
The flux plasticity is intriguingly high given that the
resolution limitations of experimental measurements(growth rate, YX/S, byproducts) are fairly narrow (~10%
variation) and YX/ATP was constrained to be between 7
and 10 g cell/mol ATP. For example, the transaldolase
(rTA) and transketolase (rTK1,rTK2) fluxes span ca
0.40 mmol/g h to that almost of a knockout (ca 0 mmol/
g h). The flux catalyzed by pyruvate kinase (rPYK) ranges
from essentially knocked out (0) to 0.93 mmol/g cell h,
which is about one third of the value of the glucose flux.
Additionally, a range of solutions arise that offer overall
ATP yields of 10, 7.3, or 7 g cell/mol ATP. Increasing
the precursor loads for DNA by three-fold did not ap-
preciably alter the number scenarios or the differences
between the scenarios (not shown) as would be expected
based on the prior remarks on the carbon demands of
DNA synthesis.
For the system, there are two degrees of freedom.
Thus, two dimensional flux plots can further readily
show the flux plasticity and well as the trends for two
different fluxes. Such plots are shown in Figure 2. In
Figure 2a different linear combination of the solutions in
Table 1 are shown to lie on the edges or within the con-
vex space. In Figure 2b, it is evident that a wide range of
fluxes can occur through the TCA cycle and pyruvate
kinase. An inverse relationship is seen between the
fluxes through pyruvate kinase and malic enzyme in
Figure 2c. In Figure 2d and the others, the shortest edge
is bounded by scenarios 3 and 4.
Each scenario is now scrutinized further. Scenario 1 in
the first row of Table 1 arises when the TCA cycle is
minimized. This solution also corresponds to maximiz-
ing biomass production rate because the product of YX/S
and the specific growth rate is maximized. Pyruvate kin-
ase activity is mid-range and fluxes catalyzed by trans-
ketolase and transaldolase are at their highest values.
This scenario is reminiscent of wild-type E. coli growing
in a glucose background where TCA cycle repression oc-
curs. Also, some workers use biomass production
maximization as an objective function to predict wild-
type fluxes [14,15], and this solution achieves that ob-
jective. Scenario 2 differs from Scenario 1 in that pyru-
vate kinase-catalyzed flux is zero and malic enzyme is
active.
When compared to scenario 1, scenarios 2, 3 and 4
are similar in a number of respects. They all offer in-
creased TCA cycle flux and reduced flux through pyru-
vate kinase. In comparison to scenario 1, scenarios 3 and
4 break out further by coordinately offering lower yields,
increased TCA cycle flux, significantly reduced flux
through pyruvate kinase, and substantially attenuated
transaldolase- and transketolase-catalyzed fluxes. Thus,
assuming that the maintenance energy of a transformant
is higher and thus YX/S and YX/ATP are lower than the
wild-type values, scenarios 3 and 4 could be candidates
as flux solution components for the transformant.
Table 1 Flux scenarios associated with macroscopically indistinguishable phenotypes*
Objective Yx/s Yx/ATP rTCA rPYK rHMP rME rTA rTK1 rTK2 rANA rCO2
1. MIN rTCA 0.45 10 0.60 0.48 1.4 0 0.43 0.43 0.36 0.57 4.64
MIN rGLU
MIN rME
MAX rHMP
MAX rTA
MAX rTK2
MAX r4
MAX r5
2. MIN rPYK 0.44 10 0.77 0 0.99 0.63 0.29 0.29 0.22 1.2 4.12
3. MAX rME 0.40 7.3 1.6 0 0.32 1.15 0.072 0.072 0 1.7 5.38
MAX rANA
MIN rHMP
MIN rTA
MIN rTK2
MIN r4
MIN r5
4. MAX rTCA 0.39 7.0 1.7 0.13 0.32 1.1 0.072 0.072 0 1.6 5.72
MAX rGLU
5. MAX rPYK 0.39 7.0 1.4 0.93 1.0 0 0.30 0.30 0.23 0.57 6.59
MIN rANA
*Symbols: cell yield on glucose (g cell/g glucose), Yx/s; cell yield on ATP (g cell/mol ATP), Yx/ATP. See Figure 1 for rTCA, rPYK, rHMP, rME, rTA, rTK1, rTK2, and rANA; rCO2 is
the net carbon dioxide flux. Flux units are mmol/g cell h. Bolded scenarios 3 and 4 indicate potential transformant solutions.
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yield possibility. The pyruvate kinase-catalyzed flux is
maximized while the TCA flux falls in between scenario
1 and scenarios 3 and 4. Overall, scenario 1 has higher
yields, low TCA, and intermediate pyruvate kinase-
catalyzed flux. In comparison two (3 and 4) have coordi-
nated: (i) increased TCA flux, (ii) low pyruvate kinase-
catalyzed flux, and (iii) diminished fluxes through trans-
aldolase and transketolase. Two scenarios (2, 5) provide
low (scenario 2) and high (scenario 5) pyruvate kinase
flux alternatives to high and lower yields, respectively.
Proteome contrast
Sixty nine differentially expressed proteins were found
based on screening at the level of p < 0.05 and a two-fold
or more change. The correlation between the 69 proteins
within the biological replicates was greater than 0.90 (see
Figure 3a). When subjected to Principal Component Ana-
lysis, the biological replicates formed distinctive and separ-
ate clusters (see inset Figure 3a). Figure 3b provides a heat
map representation as well as the distribution of Z-scores.
Overall, the replicates provided reproducible results and
pronounced differences were found between transformed
and untransformed cells.
The 69 differentially expressed proteins can be broken
down into downregulated (Figure 4a) and upregulated(Figure 4b) groups. The downregulated and upregulated
groups contain 40 and 29 proteins, respectively. Apart
from the good correlation between biological replicates
other confidence-adding features are present such as
operon- and stochiometrically-linked proteins such as
the α and β subunits of ATP synthase (3α:3β:1γ:1δ:1ε)
[16] are found to be jointly upregulated. Functional
groupings of proteins are also represented as pie chart
insets in Figures 4a and b. One can see that ribosomal
proteins comprising the 30 and 50S subunits as well as
translational factors enrich the upregulated category.
Another example is fatty acid/membrane synthesis en-
zymes are elevated such as the products of fabG, fabA,
and accB. One would expect that if random errors
accounted for most of the positives in the data, then the
results would not be as extensively and tightly grouped
by function.
Concerning metabolic enzymes, phosphofructokinase B
is downregulated in the transformant (Figure 4a). To pro-
vide perspective, the activity of phosphofructokinase B is
much less than that provided by phosphofructokinase A
[17,18], which was found to be unchanged. Phosphoglyc-
erate mutase is also considerably reduced in the transfor-
mant. To put this into context, E. coli has two
phosphoglycerate mutase activities: 2,3-biphosphoglyce-
rate-dependent (gpmA) and cofactor-independent (gpmB).
Figure 2 Flux feasibility spaces from which the values of two fluxes can be chosen to resolve the two degrees of freedom. The shaded
region encloses feasible fluxes that support a growth rate of 0.2 h-1 and a glucose and ATP yield of 0.42 ± 0.3 g cell/g glucose and 8.5 g ± 1.5 g
cell/mol ATP, respectively. In (a) different linear combinations of the solutions in Table 1 are shown to demonstrate that they fall on the edges or
within the space defined by the extreme points listed individually in Table 1. Panels (b)-(d) show alternate flux pairs.
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have comparable peak expression during growth in LB
medium while the relative amounts of the two enzymes
vary during batch growth [19]. The cofactor-independent
enzyme was found to not be statistically different in the
inc2 mutant compared to the host. Pyruvate Kinase F,
which has greater activity than the pyruvate kinase A [20],
is downregulated in the transformant. The talA gene
product Transaldolase 1 also emerged as downregulated.
In contrast to the above three enzymes, the E2 subunit
of 2-oxoglutarate dehydrogenase is elevated in the trans-
formant. Coinciding with this elevation is the increased
expression of dihydyrolipoyl dehydrogenase, which con-
stitutes the E3 component of the functional 2-
oxoglutarate dehydrogenase complex [21]. Thus, the re-
sults show a correlated increase in E2 and E3. These and
other proteins will be discussed further below.
Discussion
Figure 5 summarize the changes in metabolic enzymes we
observed. The figure is also annotated with prior studies that
manipulated individual enzymes in order to enhance PCN or
to lower the burden imposed by plasmids [22-25]. Also, as
will be developed below, some flux alteration projections and
their metabolic consequences are also shown such as
elevating ATP production. For example, Cunningham et al.knocked out pyruvate kinase in E. coli JM101 and found it to
enhance the PCN [22]. Next to Cunningham et al. appears a
triangle with a downward-directed apex indicative of the
lowered expression of we found for pyruvate kinase F in the
transformant (Figure 4a, pykF gene product). In this case, a
reduction in flux as denoted by a red arrow is a clear cut
consequence and also apart of some scenarios in Table 1.
While comparisons are not easily made due to the
plasmid and other differences between studies, the prior
reporting of upregulated TCA cycle enzymes corre-
sponds, in part, to our findings. One study reported that
transformants had increased levels of several TCA cycle
enzymes (e.g. 2-oxoglutarate dehydrogenase) while pyru-
vate kinase was decreased [26]. We also find that the
talA product Transaldolase 1is reduced in the transfor-
mant. Ow et al. [27] found that talA was one of the most
highly downregulated genes in plasmid-containing E. coli
DH5α. Likewise in chemostat studies with E. coli BL21,
the comparison of specific enzyme activities indicated
that transaldolase was more than two-fold reduced in a
transformant [28]. Thus, a number of studies find that
the same enzyme that interconverts glycolytic and hex-
ose monophosphate pathway metabolites decreases in
the presence of plasmids.
A large number of proteins related to ribosome assem-
bly, processing, and functionality are upregulated in the
Figure 3 (See legend on next page.)
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Figure 3 Characteristics of the proteomics data. (a) For the replicates sampled at mid-exponential growth phase, the protein abundances
correlated well as shown for the untransformed cells. (Inset) Principal component analysis shows that the biological replicates group as well as separate
from other conditions where red represents the transformed cells and aqua indicates the untransformed control. (b) Heat map view of the data for
transformant replicates (left; MUT1 and MUT2) and untransformed (right; WT1 and WT2).
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rplJ, rplQ, rplS, and rplY gene products. The L4, L6, L10,
L17, L19, and L25 proteins are all associated with the
50S subunit where L4 participates in the early stages of
ribosomal subunit assemblies [29]. The elevated gene
products of infB and infC, IF2 and IF3, are factors in-
volved in the early steps in initiating protein synthesis
[30]. Within the category of ribosomal proteins, the
products of rpsC, rpsQ, rpsK, rpsI, and rpsP are also in-
creased in the transformant, which represents a cluster
of proteins in the 30S subunit.
The clustered outcome for ribosomal factors may enable
ribosomes to compete for shared metabolic and energetic
resources or to maintain assembly and functionality in a
situation of increased cytoplasmic crowding arising from
deregulated plasmid replication. Finally, it has been esti-
mated that approximately one-half of the transcription ter-
minations in E. coli are Rho-dependent [31]. In the
transformant, Rho is elevated suggesting that the control
of read-through events may be increased.
Considering other protein classes, stress-related fac-
tors are either upregulated or downregulated in the
transformant.
The gene products of fkpA, tig, cspE, and proX are rep-
resented in the upregulated category. The first two assist
with protein folding where the tig gene product TF is
thought to work in tandem as well as separate from
DnaK and specialize in ribosomal and small (<20 kDa)
proteins [32,33]. CspE and ProX, in turn, provide DNA/
RNA melting and periplasmic binding capabilities for
proline and betaine, respectively [34-36]. That some
stress functions are elevated may also be reflected by in-
creased levels of enzymes that fabricate fatty acids used
for membrane construction (fabA, fabB, accB) [37-39].
Downregulated stress factors include the products of
dnaK, hns, hchA, sodA, dps, osmC, hdeA, and tpx. As
noted earlier, elevated TF may be able to provide needed
protein chaperone activity. Some can be further grouped
as (i) acid resistance factors (hchA, hdeB, and hdeA)
[40,41] and (ii) oxidative stress factors (sodA, tpx) [42].
The link between the modeling (Table 1; Figure 2) and
the proteomic outcomes can now be considered. The third
and fourth scenarios in Table 1 that concurrently
emphasize small transaldolase activity, high TCA flux, low
flux through pyruvate kinase, and lower yields on glucose
and ATP parallel the proteomic results assuming that a
change in enzyme abundance translates to reduced flux.
In some circumstances, prior work indicates that theassumption may be reasonable. For example, the E2 and
E3 components of 2-oxoglutarate dehydrogenase are ele-
vated in the transformant. 2-Oxoglutarate dehydrogenase
is not normally highly expressed in E. coli [43,44] under
glucose backgrounds and the reaction product (2-Oxoglu-
tarate) is a feedback inhibitor of citrate synthase [45].
Thus, increasing 2-oxoglutarate dehydrogenase capacity
can both reduce the feedback restriction at citrate syn-
thase and increase the flux through 2-oxoglutarate de-
hydrogenase. That is, one can argue that this enzyme may
have a significant flux control coefficient.
Considering that exerting flux control is plausible,
then increased 2-oxoglutarate dehydrogenase capacity
will manifest as increased flux through the TCA cycle.
Such increased flux will result in greater ATP produc-
tion. The outcome of greater glucose use and ATP pro-
duction per cell mass points towards the lower cell mass
yields on glucose and ATP associated with scenarios 3
and 4 in Table 1. More mechanistically, increased 2-
oxoglutarate dehydrogenase capacity provides a means
to cover the additional ATP use that will arise from
extra RNA turnover and polymerization that was noted
earlier to accompany the replication of the deregulated
plasmid.
Such an additional ATP cost would also translate to a
higher effective value of maintenance energy. This is in-
teresting because Ow et al. determined that maximizing
the maintenance energy as an objective provided the
best fit to the fluxes determined for transformed E. coli
[14]. Additionally, in our prior work on the effect of the
inc1 and inc2 mutations, we found that an impact on
growth rate occurred in a medium that was rich in pre-
cursors, but lacking in an energy source such as glucose
[4]. This observation in conjunction with the modeling
results (Table 1) further suggests that a cell transformed
with the deregulated plasmid is tighter on energy (e.g.
ATP) supply than anabolic carbon. Inducing greater 2-
oxoglutarate dehydrogenase capacity may, in turn, help
to supply the additional energy needed by providing
great oxidative flux capacity and by reducing the feed-
back inhibition at the gateway step catalyzed by citrate
synthase.
Looking further at the modeling results (Figure 2c) indi-
cates that an inverse relationship exists between the fluxes
catalyzed by pyruvate kinase and malic enzyme. Such an in-
verse relation was evident in the results of a 13C tracer and
transcriptome study performed on a pyruvate kinase (pykF)
knockout [46]. Additionally, some glycolytic enzymes were
Figure 4 (See legend on next page.)
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Figure 4 Results of proteomic contrast of cells transformed with high copy mutant plasmids and nontransformed cells. Downregulated
(a) and up regulated (b) proteins are shown. In each category, a pie chart shown in inset breaks down the proteins into functional clusters.
Functional grouping key: metabolic enzyme (solid black), translation-related (light gray), stress (medium gray/dots), and lipid-related (diagonal
stripes). * denotes an isozyme or compensating enzyme activity exists.
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kinase attenuation seems to be a common denominator in
some E. coli strains for either adaption to the presence of
plasmid [26] (Figure 4b) or for engineering enhanced plas-
mid production [22,24].
Another parallel emerges for the adaptations seen here
and those found in other studies when pyruvate kinase
was deliberately knocked out. During batch growth, car-
bon dioxide production was found to be greater in a
knockout (PB25) than a wild-type JM101 strain by ~ 40%
[47]. The flux scenarios in Table 1 that produce more ATPFigure 5 Summary overlay of the current and prior studies for plasm
downregulated (apex-down, black triangles) metabolic enzymes found in t
shown. Also shown are annotations to enzymes that others have upregula
number or improve the tolerance to plasmid burden. Based on computed
depict flux change possibilities for cells with deregulated plasmid replicatio
colors correspond to increased, decreased, and not distinguishably differenwhile having zero or very small pyruvate kinase flux (i.e. 3
and 4) also have the second and third highest values of
CO2 flux. Overall, except for acetate production [47], the
adaptations to the deregulated replication inferred from
the proteomics or suggested by the adaptive flux modeling
parallel what occurs in a pyruvate kinase knockout. The
residual pyruvate kinase activity as opposed to the zero
value of a full knockout may account for the acetate pro-
duction of plasmid-containing cells. This acetate produc-
tion can also lead to ATP formation at the substrate level
adding to that produced by the upregulated TCA cycle.id-containing cells. The upregulated (apex-up, white triangles) and
his study as an adaptation to deregulated plasmid replication are
ted or knocked out in order to assess the effect on plasmid copy
flux scenarios and projections from the proteomics, large arrows
n as compared to untransformed cells; green, red, and white arrow
t fluxes.
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ketolases connects the NADPH-producing steps of the
hexose monophosphate (HMP) pathway to glycolysis. The
HMP pathway along with malic enzyme and isocitrate de-
hydrogenase supply the cell with NADPH along with
some transhydrogenase-mediated conversion of NADH.
The flux solutions in Table 1 indicate that scenarios exist
such as 3 and 4 where malic enzyme can provide about
one third of the total NADPH. Thus, in circumstances
where malic enzyme is present and it can thermodynamic-
ally operate in the NADPH-producing direction, the hex-
ose monophosphate pathway can be relieved somewhat
from its task of NADPH supply. Note, however, apart
from the absolute value of the flux into the HMP pathway
(rHMP), the difference between this value and the return
fluxes represents the net available for biosynthesis, which
is also an important characteristic.
Other metabolic aspects now involve fluxes that may
not have substantially changed. Phosphofructokinase A
is comparable in the host and transformant whereas only
the minor phosphofructokinase B activity was found to
decrease. An irreversible feedback-regulated enzyme
such as Phosphofructokinase A is generally not flux con-
trolling [48]; hence, the total gateway glycolytic capaci-
ties of the mutant and host may not be substantially
different. Also, it has been suggested that glycolysis has
a lot of capacity and the flux is controlled through ATP
turnover in an acceptor control-like manner [49]. Thus,
the changes in glycolytic enzymes may have more to do
with (i) altering the levels of metabolites and (ii) how
fluxes may be distributed between glycolysis and the
hexose monophosphate pathway than total fluxes of tri-
oses. This is suggested further by most of the changes
occur in enzymes that based on standard conditions, are
viewed as catalyzing reversible reactions. Some maintain
that reactions at or close to equilibrium provide a low
degree of flux control [48]. Overall, one simple interpret-
ation is extra carbon is sent to the TCA cycle in the
transformant, which as mentioned earlier, can be proc-
essed by upregulated 2-oxoglutarate dehydrogenase. The
high gain of ATP produced per differential mole of TCA
flux can, in turn, contribute to the transformant’s in-
creased ATP demand.
Conclusions
In the context of antisense RNA selection for plasmid-
containing cells and thus no plasmid-driven protein syn-
thesis, E. coli growing on minimal media displays very
similar phenotypic characteristics with respect to growth
rate, yield on glucose, and byproducts when either trans-
formed with a deregulated plasmid or not transformed.
We conclude that within the narrow bounds of experi-
mentally quantitated phenotypic descriptors, significant
flux plasticity exists where apparently similar phenotypescan have quite different underlying fluxes. Moreover, we
conclude that this plasticity appears to constitute an
adaptive space that the cells used to contend with the al-
tered energetics (e.g. RNA turnover/repolymerization)
associated with deregulated plasmid replication. A sub-
set of the solutions coordinately presented lower yield
on glucose and ATP, low flux through pyruvate kinase,
increased TCA cycle flux, and nil transaldolase flux.
Proteomic experiments yielded results where increases
or decreases in pyruvate kinase, transaldolase 1, and 2-
oxoglutarate dehydrogenase paralleled the corresponding
predicted fluxes in the subset. These changes and some
relationships to prior studies are summarized in
Figure 5.
Proteomic characterization also indicated that increases
in 30 and 50S ribosomal proteins occurred in the transfor-
mant among other clustered changes. We suggest that the
increased cytoplasmic crowding imposed by the thousands
of plasmids may necessitate adaptations that improve the
competiveness of binding and recognition associated with
other large macromolecule-based processes. Apart from
these particular results and conclusions, including a range
for experimental measurements may also be useful for
other flux balance analysis/optimization applications in
order to fully map the flux solution space.
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